Intracellular Nucleotide Levels during Coadministration of Tenofovir Disoproxil Fumarate and Didanosine in HIV-1-Infected Patients

por Hawkins, Trevor, Veikley, Wenoah, Durand-Gasselin, Lucie, Babusis, Darius, Reddy, Y. Sunila, Flaherty, John F., Ray, Adrian S.
Publicado 2011

Fanconi Syndrome Accompanied by Renal Function Decline with Tenofovir Disoproxil Fumarate: A Prospective, Case-Control Study of Predictors and Resolution in HIV-Infected Patients

por Gupta, Samir K., Anderson, Albert M., Ebrahimi, Ramin, Fralich, Todd, Graham, Hiba, Scharen-Guivel, Valeska, Flaherty, John F., Fortin, Claude, Kalayjian, Robert C., Rachlis, Anita, Wyatt, Christina M.
Publicado 2014

Efficacy of tenofovir disoproxil fumarate at 240 weeks in patients with chronic hepatitis B with high baseline viral load

por Gordon, Stuart C, Krastev, Zahary, Horban, Andrzej, Petersen, Jörg, Sperl, Jan, Dinh, Phillip, Martins, Eduardo B, Yee, Leland J, Flaherty, John F, Kitrinos, Kathryn M, Rustgi, Vinod K, Marcellin, Patrick
Publicado 2013

Durability of Hepatitis B Surface Antigen Loss With Nucleotide Analogue and Peginterferon Therapy in Patients With Chronic Hepatitis B

por Lok, Anna S., Zoulim, Fabien, Dusheiko, Geoffrey, Chan, Henry L.Y., Buti, Maria, Ghany, Marc G., Gaggar, Anuj, Yang, Jenny C., Wu, George, Flaherty, John F., Subramanian, G. Mani, Locarnini, Stephen, Marcellin, Patrick
Publicado en Hepatol Commun (2019)

Treatment with tenofovir disoproxil fumarate or entecavir in chronic hepatitis B virus‐infected patients with renal impairment: results from a 7‐year, multicentre retrospective coh...

por Lampertico, Pietro, Berg, Thomas, Buti, Maria, Pathil, Anita, Petersen, Joerg, Ryder, Stephen D., Zoulim, Fabien, Botros, Irina, Flaherty, John F., Jump, Belinda, Op den Brouw, Marjoleine L., van Troostenburg, Anna, Ramroth, Heribert
Publicado en Aliment Pharmacol Ther (2020)

Seven-Year Efficacy and Safety of Treatment with Tenofovir Disoproxil Fumarate for Chronic Hepatitis B Virus Infection

por Buti, Maria, Tsai, Naoky, Petersen, Joerg, Flisiak, Robert, Gurel, Selim, Krastev, Zahary, Aguilar Schall, Raul, Flaherty, John F., Martins, Eduardo B., Charuworn, Prista, Kitrinos, Kathryn M., Mani Subramanian, G., Gane, Edward, Marcellin, Patrick
Publicado en Dig Dis Sci (2014)

Antiviral kinetics of tenofovir alafenamide and tenofovir disoproxil fumarate over 24 weeks in women of childbearing potential with chronic HBV

por Pan, Calvin Q., Chang, Ting-Tsung, Bae, Si Hyun, Brunetto, Maurizia, Seto, Wai-Kay, Coffin, Carla S., Tan, Susanna K., Mo, Shuyuan, Flaherty, John F., Gaggar, Anuj, Nguyen, Mindie H., Çelen, Mustafa Kemal, Thompson, Alexander, Gane, Edward J.
Publicado en PLoS One (2021)

Long-term clinical outcomes in cirrhotic chronic hepatitis B patients treated with tenofovir disoproxil fumarate for up to 5 years

por Buti, Maria, Fung, Scott, Gane, Edward, Afdhal, Nezam H., Flisiak, Robert, Gurel, Selim, Flaherty, John F., Martins, Eduardo B., Yee, Leland J., Dinh, Phillip, Bornstein, Jeffrey D., Mani Subramanian, G., Janssen, Harry L. A., George, Jacob, Marcellin, Patrick
Publicado en Hepatol Int (2015)

Single-Dose and Steady-State Pharmacokinetics of Tenofovir Disoproxil Fumarate in Human Immunodeficiency Virus-Infected Children

por Hazra, Rohan, Balis, Frank M., Tullio, Antonella N., DeCarlo, Ellen, Worrell, Carol J., Steinberg, Seth M., Flaherty, John F., Yale, Kitty, Poblenz, Marianne, Kearney, Brian P., Zhong, Lijie, Coakley, Dion F., Blanche, Stephane, Bresson, Jean Louis, Zuckerman, Judith A., Zeichner, Steven L.
Publicado 2004

Kinetics of hepatitis B surface antigen loss in patients with HBeAg-positive chronic hepatitis B treated with tenofovir disoproxil fumarate

por Marcellin, Patrick, Buti, Maria, Krastev, Zahari, de Man, Robert A., Zeuzem, Stefan, Lou, Lillian, Gaggar, Anuj, Flaherty, John F., Massetto, Benedetta, Lin, Lanjia, Dinh, Phillip, Subramanian, G. Mani, McHutchison, John G., Flisiak, Robert, Gurel, Selim, Dusheiko, Geoffrey M., Heathcote, E. Jenny
Publicado en J Hepatol (2014)

No Resistance to Tenofovir Alafenamide Detected through 96 Weeks of Treatment in Patients with Chronic Hepatitis B Infection

por Cathcart, Andrea L., Chan, Henry Lik-Yuen, Bhardwaj, Neeru, Liu, Yang, Marcellin, Patrick, Pan, Calvin Q., Shalimar, Buti, Maria, Cox, Stephanie, Parhy, Bandita, Zhou, Eric, Martin, Ross, Chang, Silvia, Lin, Lanjia, Flaherty, John F., Kitrinos, Kathryn M., Gaggar, Anuj, Izumi, Namiki, Lim, Young-Suk
Publicado en Antimicrob Agents Chemother (2018)

3-year Treatment of Tenofovir Alafenamide vs. Tenofovir Disoproxil Fumarate for Chronic HBV Infection in China

por Hou, Jinlin, Ning, Qin, Duan, Zhongping, Chen, You, Xie, Qing, Wang, Fu-Sheng, Zhang, Lunli, Wu, Shanming, Tang, Hong, Li, Jun, Lin, Feng, Yang, Yongfeng, Gong, Guozhong, Flaherty, John F., Gaggar, Anuj, Mo, Shuyuan, Cheng, Cong, Camus, Gregory, Chen, Chengwei, Huang, Yan, Jia, Jidong, Zhang, Mingxiang
Publicado en J Clin Transl Hepatol (2021)